Proteoral exported to a multinational Company in Darmstadt, Germany
2023-08-11
Safety and efficacy functionality studies of Proteoral are performed in an international interlaboratory collaboration between...
Proteoral Oral Biologics transporter
Proteoral is the first excipient transports biological active pharmaceutical ingredients through the intestine by safely opening intercellular junctions of the intestinal epithelium
Learn More Beyond the needle
Most therapeutic biological products are injectable. However, oral medications are the patients first choice of drug intake. Proteoral is the solution as it transports biological active pharmaceutical ingredients through the intestine, using pills instead of shots.
Proteoral is friendly to humans and the planet.
Your manufacturing process
1 | Solution
A homogeneous solution of your biological pharmaceutical active ingredient and the Proteoral excipient is obtained.
2 | Powder
A homogeneous powder suitable for the encapsulation of your biological pharmaceutical active ingredient and the Proteoral excipient is obtained.
3 | Encapsulated
Your active ingredients and Proteoral are encapsulated in capsules that protect from stomach action and are quick - release at the small intestine.The active ingredient released is rapidly absorbed in the intestine with Proteoral into the bloodstream reaching its site of action.
4 | Medicinal product
Be a game changer in your market with your oral biological product.
Safety for your company and patients
Safe and effective Proteoral
Our versatile formulation platform protects your active ingredients in capsules and releases them in the small intestine. The active ingredient is absorbed with Proteoral into the bloodstream.
.Initial non-clinical trial had demonstrated that Proteoral is safe and effective.
Why choose us
Proteoral is a recombinant protein produced by biotechnology with low manufacturing costs. Its mechanism of action is completely innocuous, it opens the intercellular junctions of the intestine and transports your product to the bloodstream, reaches the target site and fulfills its therapeutic action. Be a pioneer in your segment with your oral biological medicinal product!
High Quality Oral Biologics medicinal products by Design.
Faster pharmacokinetic and pharmacodynamic studies.
Manufacture in accordance to GLP/GMP preclinical and clinical phases standards
Technical transfer to the manufacturing site Supported
Production and on-site troubleshooting supported.
Friendly to humans and the planet.
Mission
We benefit the lives of humans by transforming the industry through oral biological medicines.
Vision
To be a prefered partner in the pharmaceutical industry and medicine by incorporating new products and scientific discoveries into the market.
Values
Through our ethics, commitment to medicine, and global vision, we contribute to Wellness and Health with a global impact.
Our Investors
We connect, inspire, empower technologists and scientists become the innovations found in the world’s most impactful companies.
Top Pre-Accelerator & Incubator In Silicon Valley.
We partner with those who rebuild society through empathy and technology.
Fondo Fiduciario Para el Desarrollo de Capital Emprendedor (FONDCE).
Our allies
IB50K
Universidad Austral
Centro de Medicina Comparada
Universidad del Litoral
Universidad de Buenos Aires
Frequently Asked Questions
What is the biological activity of Proteoral?
Proteoral is a pore-forming protein opening the intercellular junctions of the small intestine.
What is the type of transportation?
Biologics active ingredients are transported by paracellular transepithelial passage through the small intestine and absorbed into the bloodstream.
What are the molecules it transports?
Proteoral can transport macromolecules: Hormones, monoclonal antibodies, peptides, polysaccharides and other macromolecules.
Is there any size limit for loading?
Proteoral transports macromolecules from peptides from 5 Kda to more than 147 Kda.
When does Proteoral have its peak activity?
The activity of Proteoral begins 20 minutes after the release of the product in the intestine, and the greatest absorption is achieved 2 hours after oral -administration.
What is the region of maximum absorption in the intestine?
The region of maximum absorption is the duodenum and jejunum-ileum in the small intestine.
News
Milena Batalla, Ph.D. author on . All-natural 5-MeO-DMT sigma receptor 1 agonist and its therapeutic...
2023-07-31
The sigma-1 receptor S1R is a chaperone that resides mainly at the mitochondrion-associated endoplasmic reticulum ER membrane...
PANARUM joined to CONICET to celebrate the 65 Anniversary 1958 – 2023 of the Consejo Nacional de Investigaciones...
2023-04-10
CONICET is the main organization dedicated to the promotion of Science and Technology in Argentina. Sixty-five years renewing...
STANFORD Latino Entrepreneurship Initiative Education SCALING Program GRADUATION CEREMONY.
2022-12-03
After 2 intense months of work and activities in the executive business program of academic excellence for Latino entrepreneurs...
Milena Batalla, Ph. D. joins to the STANFORD Latino Entrepreneurship Initiative Education SCALING Program....
2022-10-01
We Joined to a powerful network of Latino entrepreneurs we are committed to growing our businesses. I enter the program...
Meeting of Women Entrepreneurs at the Secretariat of Industry and Productive Development of Argentina
2022-09-21
On September 21, the first meeting of female entrepreneurs in Argentina was held at the Ministry of Industry and Productive...
Draper Startup House Ventures is pleased to back Panarum Corp, which is revolutionizing oral proteins.
2022-06-01
Panarum Corp is a pharmaceutical technology company. Proteoral® is the transporter of excipients of biological products...
Proteoral introduced at The American Association of Pharmaceutical Scientists Virtual Workshop
2022-04-11
Milena Batalla, Ph. D introduced Proteoral into Drug Carriers at ADME from Bench to Bed. American Association of Pharmaceutical...
Panarum at The Silicon Review magazine, 1st September 2021
2021-09-01
We are a company transforming the pharmaceutical industry, which is why our venture capital partners have invested in us...
Milena Batalla, PANARUM CEO invited among Latin American women in Science in the 25th issue of Quimiofilia...
2021-08-03
In this issue we have been summoned through Milena testimony to be part of academic and industrial researchers, teachers...
Panarum the winner in Draper University First Position on Demo Day
2021-07-28
Panarum Corporation was the winner at the Demo Day Journey at Draper University The Top Accelerator in The Silicon Valley....
Entrepreneurship to innovate
2021-07-13
In this note we explain what Proteoral is, our protein transporter through the intestine, what is the advantage of oral transport...
Milena Batalla was selected to participate in the Draper University Summer 2021 Pre-Accelerator Program.
2021-07-05
Milena Batalla was selected and received a 100% grant to be part of the Summer 2021 Hero Training Program from July 5 to...
PANARUM introduced Proteoral in the Casa Rosada, Argentina
2021-06-11
Milena Batalla introduced Panarum Corp, at the Casa Rosada as part of the launch of the 11th edition of the IB50K Contest,...
Draper Cygnus invested US$640k in Panarum, an Argentine biotech creates Proteoral to replace the use...
2020-12-21
No needles, just take a pill. Panarum produces Proteoral, a capsule-enclosed recombinant fusion protein that serves as a...
Panarum in the Magazine of Drug Delivery New Oral Delivery Systems # 109
2020-07-31
I am really very happy to present you with information and intelligence on the latest trends and developments in and around...
Contact Us
- · U.S.A
Panarum Corp:
112 Capitol Trail, Newark
Newark - DE 19711, United States. - · Silicon Valley
Hero City en Draper University
55 E. 3rd Avenue,
San Mateo CA 94401, Estados Unidos. - · Argentina
Panarum lab:
Av. Independencia 3150 - C.P. 1225
Capital Federal
